Fulcrum Therapeutics, Inc. (FULC)
3.755
+0.08
(+2.32%)
USD |
NASDAQ |
Oct 08, 16:00
3.755
0.00 (0.00%)
After-Hours: 17:51
Fulcrum Therapeutics Max Drawdown (5Y) : 92.70% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 92.70% |
| August 31, 2026 | 92.70% |
| July 31, 2026 | 92.70% |
| June 30, 2026 | 92.70% |
| May 31, 2026 | 92.70% |
| April 30, 2026 | 92.70% |
| March 31, 2026 | 92.70% |
| February 28, 2026 | 92.70% |
| January 31, 2026 | 92.70% |
| December 31, 2025 | 92.70% |
| November 30, 2025 | 92.70% |
| October 31, 2025 | 92.70% |
| September 30, 2025 | 92.70% |
| August 31, 2025 | 92.70% |
| July 31, 2025 | 92.70% |
| June 30, 2025 | 92.70% |
| May 31, 2025 | 92.70% |
| April 30, 2025 | 92.70% |
| March 31, 2025 | 92.70% |
| February 28, 2025 | 92.70% |
| January 31, 2025 | 92.70% |
| December 31, 2024 | 92.70% |
| November 30, 2024 | 92.70% |
| October 31, 2024 | 92.70% |
| September 30, 2024 | 92.70% |
| Date | Value |
|---|---|
| August 31, 2024 | 92.70% |
| July 31, 2024 | 92.70% |
| June 30, 2024 | 92.70% |
| May 31, 2024 | 92.70% |
| April 30, 2024 | 92.70% |
| March 31, 2024 | 92.70% |
| February 29, 2024 | 92.70% |
| January 31, 2024 | 92.70% |
| December 31, 2023 | 92.70% |
| November 30, 2023 | 92.70% |
| October 31, 2023 | 92.70% |
| September 30, 2023 | 92.70% |
| August 31, 2023 | 92.70% |
| July 31, 2023 | 92.70% |
| June 30, 2023 | 92.70% |
| May 31, 2023 | 92.70% |
| April 30, 2023 | 92.70% |
| March 31, 2023 | 90.86% |
| February 28, 2023 | 86.44% |
| January 31, 2023 | 86.44% |
| December 31, 2022 | 86.44% |
| November 30, 2022 | 86.44% |
| October 31, 2022 | 86.44% |
| September 30, 2022 | 86.44% |
| August 31, 2022 | 86.44% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Cocrystal Pharma, Inc. | 97.93% |
| CNBX Pharmaceuticals, Inc. | 100.0% |
| Arvinas, Inc. | 94.37% |
| Definium Therapeutics, Inc. | 96.96% |
| LeonaBio, Inc. | 99.33% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -63.52 |
| Beta (5Y) | 2.633 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 116.6% |
| Historical Sharpe Ratio (5Y) | -0.3189 |
| Historical Sortino (5Y) | -0.6147 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 50.36% |